COX15

COX15 is a mitochondrial inner membrane heme A synthase that catalyzes the conversion of heme O to heme A, an essential prosthetic group of cytochrome c oxidase (complex IV), thereby serving as a critical node in mitochondrial respiratory chain biogenesis (PMID:9228094, PMID:12474143). Beyond its enzymatic role, COX15 physically associates with early Cox1-containing cytochrome c oxidase assembly intermediates and cooperates with SURF1/Shy1 for heme insertion into Cox1; it also forms homooligomers and interacts with the cytochrome bc1 dimer within respiratory supercomplexes (PMID:23979592, PMID:30181213). Loss of COX15 in mouse oocytes disrupts iron and reactive oxygen species homeostasis, triggering mitochondrial dysfunction and ferroptosis that is rescued by ferrostatin-1, and biallelic COX15 mutations in humans cause cytochrome c oxidase deficiency (PMID:39471219, PMID:12474143). COX15 is also the primary target of the antiparasitic compound cruzidione, which inhibits heme A synthesis and COX activity upon NADH-dehydrogenase-dependent bioactivation (PMID:41369564).

1. 1997 High

   Establishing COX15 as a mitochondrial inner membrane protein required for cytochrome c oxidase assembly resolved the question of where the gene product acts and showed its role is specific to COX biogenesis rather than general heme or copper metabolism.

   Evidence Genetic complementation, subcellular fractionation, and protease-protection assays in yeast cox15 mutants

   PMID:9228094

   Open questions at the time

   • Enzymatic activity of Cox15 was not identified
   • Mechanism of COX assembly promotion unknown
   • Human ortholog not yet characterized
2. 1998 High

   Identification and mitochondrial import of the human COX15 protein established ortholog conservation and opened the gene to investigation in human mitochondrial disease.

   Evidence In vitro mitochondrial import assay with protease protection and sequence homology analysis

   PMID:9878253

   Open questions at the time

   • Functional complementation in human cells not yet demonstrated
   • No disease-causing mutations identified
3. 2002 High

   Demonstrating that patient COX15 mutations reduce heme A while accumulating heme O — and that COX15 overexpression rescues both heme A content and COX activity — established COX15 as the heme A synthase catalyzing the final step of heme A biosynthesis and linked its deficiency to human cytochrome c oxidase deficiency.

   Evidence Retroviral complementation in patient fibroblasts with heme A/O quantification and COX activity measurements

   PMID:12474143

   Open questions at the time

   • Structural basis of catalysis unknown
   • Whether COX15 has roles beyond heme A synthesis not addressed
   • Mechanism of heme A transfer to Cox1 not determined
4. 2013 High

   Showing that Cox15 physically associates with Cox1-containing assembly intermediates and with Shy1 — yet can engage Cox1 independently of Shy1 — revealed that COX15 has an additional scaffolding/delivery role in heme insertion into early COX intermediates beyond bulk heme A production.

   Evidence Reciprocal co-immunoprecipitation, mass spectrometry, and genetic epistasis analysis in yeast

   PMID:23979592

   Open questions at the time

   • Direct heme transfer from Cox15 to Cox1 not reconstituted in vitro
   • Stoichiometry and dynamics of the Cox15–Shy1–Cox1 interaction unknown
   • Whether the same associations occur in mammalian mitochondria untested
5. 2018 Medium

   Discovery that Cox15 forms homooligomers and associates with the cytochrome bc1 dimer (via Cor1) even in the absence of supercomplexes extended its role to the interface of respiratory chain supercomplex organization.

   Evidence Co-immunoprecipitation and native gel electrophoresis in yeast assembly mutant backgrounds

   PMID:30181213

   Open questions at the time

   • Functional significance of Cox15–bc1 interaction not established
   • Single-lab study; not independently confirmed
   • Whether oligomerization is required for enzymatic activity unknown
6. 2024 High

   Oocyte-specific Cox15 knockout in mice revealed that loss of COX15 causes iron dysregulation and ferroptosis — rescued by ferrostatin-1 — connecting mitochondrial heme A synthesis to cellular iron homeostasis and programmed cell death in a physiological context.

   Evidence Conditional knockout mouse model with ROS/Fe²⁺ measurements and ferroptosis inhibitor rescue; human whole-exome sequencing validation

   PMID:39471219

   Open questions at the time

   • Molecular pathway linking heme A deficiency to iron accumulation not delineated
   • Whether ferroptosis occurs in other cell types upon COX15 loss not tested
7. 2025 Medium

   Identification of Cox15 as the primary target of the antiparasitic cruzidione — supported by a sensitizing active-site mutation and heterologous enzyme replacement — provided pharmacological validation of COX15 as a druggable enzyme and revealed NADH-dehydrogenase-dependent bioactivation as a prerequisite for inhibition.

   Evidence Yeast genetic screen (S429F), heterologous expression of T. cruzi Cox15, COX activity, heme content, and O₂ consumption assays

   PMID:41369564

   Open questions at the time

   • Binding site and inhibition mechanism of cruzidione on Cox15 not structurally resolved
   • Selectivity between host and parasite Cox15 enzymes not quantified
   • Single-lab study
8. 2026 Medium

   Modeling the patient-associated Gly78Arg mutation in yeast showed that protein instability — rather than catalytic site disruption per se — is sufficient to cause inadequate heme A synthesis and defective COX assembly, establishing protein stability as a critical determinant of heme A synthase function.

   Evidence Yeast homologous mutation modeling with Western blotting for stability, heme a quantification, and COX assembly analysis

   PMID:42001949

   Open questions at the time

   • Structural basis of instability not resolved
   • No chaperone or quality-control factors for Cox15 turnover identified
   • Single-lab study

• Key outstanding questions include the atomic structure of COX15, the mechanism of heme A transfer from COX15 to Cox1, the functional role of Cox15 oligomerization and bc1 association, and the molecular pathway linking heme A deficiency to iron dysregulation and ferroptosis.
• No high-resolution structure of COX15
• In vitro reconstitution of heme A transfer not achieved
• Molecular link between heme A loss and ferroptosis undefined